Short answer
TB-500 is a fragment of thymosin beta-4, a naturally occurring 43-amino-acid protein that binds actin. Because actin controls cell shape and movement, thymosin beta-4 is studied in cell migration and tissue remodeling research models. TB-500 is sold as a lyophilized research powder.
What is thymosin beta-4?
Thymosin beta-4 is one of the most abundant actin-binding proteins in cells. It keeps actin monomers available for building the cytoskeleton - the internal scaffold that lets cells change shape and move [1]. The complete amino acid sequence of the protein was determined in 1981 by Low and colleagues, who isolated it from calf thymus and showed that it is a 43-amino-acid polypeptide [4].
TB-500 refers to a fragment of this protein used in research. Because the fragment retains actin-binding activity, it is used as a tool in studies of cell motility and related pathways. The distinction between the full-length protein and the TB-500 fragment matters for experimental design: a researcher studying the biology of the native protein may prefer material closer to the full sequence, while a researcher testing a specific fragment will want the fragment itself with identity confirmed by mass spectrometry.
Where thymosin beta-4 comes from
Thymosin beta-4 was first isolated from calf thymus tissue, which is how it got its name, but it is by no means limited to the thymus. It is expressed widely across tissues and is among the most abundant actin-sequestering proteins in the body, found in nearly every cell type examined [3]. This broad distribution is one reason researchers look at it in so many different systems - cardiac, dermal, neural and vascular - rather than viewing it as a thymus-specific molecule.
The name can be a source of confusion. The thymosins are a family of small proteins historically grouped by their discovery in thymus extracts, and thymosin beta-4 is the main beta-thymosin in most cells. The research form known as TB-500 is a fragment of this protein rather than a distinct gene product, so the experimental material, the full-length protein and the family name should not be conflated when reading the literature [3][4].
The actin hypothesis in detail
The biology behind TB-500 starts with actin. Actin exists in cells in two states: as free monomers called G-actin and as long polymers called F-actin that make up the cytoskeleton. Cells move by polymerizing G-actin at the leading edge, pushing the membrane forward, and depolymerizing it at the rear. This continuous assembly and disassembly is what allows a cell to crawl across a surface or change shape.
Thymosin beta-4 fits into this picture as the major actin-sequestering protein in eukaryotic cells [3]. It binds G-actin monomers and holds them in a reserve pool, preventing them from polymerizing until the cell needs them. This "moonlighting" protein therefore does two jobs at once: it buffers the actin pool for normal cytoskeleton maintenance and, when the cell needs to migrate, it makes monomers available for building new filaments [3].
A landmark Nature paper added a signaling dimension. Bock-Marquette and colleagues showed that thymosin beta-4 activates integrin-linked kinase (ILK), a protein that couples the actin cytoskeleton to survival and migration signaling in cardiac cells [1]. This connects the simple actin-buffering story to a broader cellular signaling network and is one reason thymosin beta-4 has attracted attention across cardiac, dermal and neural research.
What the research shows
A 2005 review in Trends in Molecular Medicine framed thymosin beta-4 as a protein that "moonlights" to repair injured tissues, summarizing its actin-sequestering role and its reported effects in wound and cardiac repair models [3]. That review remains a widely cited summary of the mechanistic picture.
Reading the evidence critically
The thymosin beta-4 literature is strong on mechanism but thin on large-scale human studies. The founding observations - the sequence work from 1981 [4], the actin-sequestering characterization and the cardiac repair work in the Nature paper [1] - are well established at the cell and animal level. However, most of what is reported for the TB-500 fragment specifically comes from preclinical models, and claims about its behavior in people should be met with the same skepticism applied to any research peptide.
A critical reader should also separate the biology of the native protein from the biology of the fragment. Effects reported for full-length thymosin beta-4 do not automatically transfer to a shorter fragment, which is why identity verification matters: the COA should state the exact construct, and mass spectrometry should confirm it. When comparing studies, note which material each paper actually used.
Why cell movement matters in repair research
To understand why an actin-binding protein draws so much attention, it helps to see why cell movement is central to tissue repair. When tissue is damaged, cells from the surrounding area must move into the site - migrating across surfaces, changing shape and re-forming organized structures. Every one of those behaviors depends on the actin cytoskeleton. Cells extend protrusions at the leading edge, polymerize actin to push forward, and release old adhesions at the rear to keep moving.
Thymosin beta-4 sits at the supply side of this system. By sequestering G-actin monomers, it controls how much raw material is available for polymerization, and by activating integrin-linked kinase it links that pool to survival signaling [1][3]. This is why researchers in cardiac, dermal and neural repair models have all studied the same protein: whatever the tissue, the need for coordinated cell movement and survival is the same, and the actin system is the common machinery.
Key facts at a glance
| Property | Detail |
|---|---|
| Full protein | Thymosin beta-4 (43 amino acids) |
| Sequence described | 1981, by Low, Hu and Goldstein |
| Research form | TB-500 fragment |
| Main function studied | Actin binding and cell migration |
| Key signaling | Actin sequestration, integrin-linked kinase |
| Research themes | Cardiac, dermal, neural repair models |
| Typical form | Lyophilized powder |
| Purity expectation | 99%+ by HPLC |
TB-500 versus the full protein
A common question in the lab is whether to study thymosin beta-4 as the full 43-amino-acid protein or as the TB-500 fragment. There is no universal answer; the choice depends on the hypothesis. Full-length material is appropriate when the experiment concerns the native protein, its folding, or its interactions in a complex model. A fragment such as TB-500 is appropriate when the experiment is testing a specific region or when a shorter material is easier to handle and verify. In all cases, the sequence must be confirmed by mass spectrometry, and the COA should state exactly which construct you are receiving.
Experimental considerations
Several design points recur in thymosin beta-4 research. Because the mechanism is actin-based, migration assays - such as scratch-wound or transwell migration experiments - are the most direct functional readouts, and they pair naturally with actin staining to visualize the cytoskeleton. Survival-related readouts connect to the integrin-linked kinase signaling described in the cardiac literature [1], so assays that measure apoptosis or cell viability can complement a migration study.
Two practical cautions are worth stating. First, the salt form and counter-ion can influence cell-based assays, so confirm them on the COA. Second, because the material is a protein fragment rather than a heavily modified peptide, storage discipline - cold, dry, protected from light - is especially important to preserve activity. Reconstitution should follow the protocol solvent exactly, and leftover solution should not be repeatedly frozen and thawed.
Storage and handling
TB-500 is typically supplied as a lyophilized powder and follows standard peptide storage practice:
Our peptide storage guide covers these points in more detail.
What to check before buying TB-500
Compare BPC-157 vs TB-500 if you are deciding between the two peptides, or browse TB-500 product options.
FAQ
What is TB-500?
A research fragment of thymosin beta-4, a 43-amino-acid actin-binding protein.
What is thymosin beta-4?
A small, abundant protein that binds actin monomers and supports cell movement.
How is TB-500 studied?
In cell migration, actin dynamics, cardiac and dermal repair models.
Is TB-500 for human use?
No, laboratory research use only.